Global Glaucoma Drainage Devices
Market Report
2025
As per Cognitive Market Research's latest published report, The U.S. Glaucoma Drainage Devices market size will be $2,425.55 Million by 2028. The U.S. Glaucoma Drainage Devices Industry's Compound Annual Growth Rate will be 20.23% from 2023 to 2030.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Glaucoma Drainage Devices Market Report 2025.
As per Cognitive Market Research's latest published report, The U.S. Glaucoma Drainage Devices market size will be $2,425.55 Million by 2028. The U.S. Glaucoma Drainage Devices Industry's Compound Annual Growth Rate will be 20.23% from 2023 to 2030.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Glaucoma Drainage Devices Market Sales Revenue | 121212 | 121212 | 121212 | 20.23% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by Application |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Glaucoma Drainage Devices industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Glaucoma Drainage Devices Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Glaucoma is a group of eye diseases characterized by progressive, irreversible and largely asymptomatic vision loss in which elevated levels of IOP are often associated with optic nerve damage that can cause blindness. While some glaucoma patients do not experience an increase in IOP, it is widely considered a major risk factor in glaucoma’s progression, and reduction in IOP is the only clinically proven treatment. Elevated IOP occurs when aqueous humor is not circulating normally or properly draining from the front part of the eye. Treating glaucoma is typically aimed at lowering intraocular pressure for patients with normal or elevated pressure. Most commonly, glaucoma is managed using medication (e.g., drops). For cases requiring additional intervention, laser-based procedures and conventional surgical techniques, such as filtration surgery and tube shunts, have typically been used to lower IOP. Filtration surgeries, such as trabeculectomy, involve the creation of a new channel to drain aqueous humor from inside the eye. Similarly, tube shunts establish a route for fluid to exit through an implanted device. More recently, a new category of device and procedure-based surgical intervention, known as MIGS, has emerged and is experiencing rapid adoption among both glaucoma and cataract specialists. Surgery involves either laser treatment or making a cut in the eye to reduce the intraocular pressure. Surgery can help lower pressure when medication is not sufficient. However, it cannot reverse vision loss.
Glaucoma can cause blindness if it is left untreated. And unfortunately, approximately 10% of people with glaucoma who receive proper treatment still experience loss of vision. Glaucoma is not curable, and vision lost cannot be regained. With medication and/or surgery, it is possible to halt further loss of vision. Since open-angle glaucoma is a chronic condition, it must be monitored for life. Diagnosis is the first step to preserving your vision. According to the Center for Disease Control and Prevention (CDC), approximately 2.7 million people in the U.S. were affected by glaucoma in 2016, making glaucoma one of the leading causes of blindness in the country. According to the data provided by Glaucoma Research Foundation, it is estimated that over 3 million
Americans have glaucoma but only half of those know they have it and more than 120,000 are blind from glaucoma, accounting for 9% to 12% of all cases of blindness. Glaucoma is the second leading cause of blindness in the world, according to the World Health Organization. After cataracts, glaucoma is the leading cause of blindness among African Americans. The most common form, open-angle glaucoma, accounts for 19% of all blindness among
African Americans compared to 6% in Caucasians. The growth in the cases of glaucoma is anticipated to fuel the growth of the United States glaucoma surgery devices.
We have various report editions of Glaucoma Drainage Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. Allergan PLC manufactures specialty pharmaceuticals. The company develops, manufactures, and distributes generic, brand, and over-the-counter products. Allergan offers its pharmaceutical drugs around the world. Allergan is now part of AbbVie.
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world's leading causes of blindness. They have developed a proprietary bio-activated pharmaceutical therapy for the treatment of a corneal disorder, keratoconus that was approved by the U.S. Food and Drug Administration (FDA) in 2016. They are also developing a pipeline of surgical devices, sustained pharmaceutical therapies, and implantable biosensors intended to treat glaucoma progression, corneal disorders such as keratoconus, dry eye and refractive vision correction, and retinal diseases such as neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME). Our commercial solutions and development-stage product candidates include:
• MIGS products that involve the insertion of a micro-scale device or drug delivery system designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathway for patients suffering from glaucoma and MIGS biosensors to measure pressure within the eye
• Topical pharmaceuticals that are bio-activated on the eye by one of our proprietary systems intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders or refractive disorders
• Topical pharmaceuticals that are applied to the eyelid and meant to treat dry eye and other conditions
• Proprietary micro-invasive, bio-erodible sustained release drug delivery implants that are designed to elute pharmaceuticals over time to improve the vision of patients impacted by retinal diseases such as AMD, DME, retinal vein occlusion (RVO), and diabetic retinopathy (DR).
Top Companies Market Share in Glaucoma Drainage Devices Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Region and country analysis section of Glaucoma Drainage Devices Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Glaucoma Drainage Devices market.
The current report Scope analyzes Glaucoma Drainage Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Glaucoma Drainage Devices Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Glaucoma Drainage Devices Industry growth. Glaucoma Drainage Devices market has been segmented with the help of its Type, Application , and others. Glaucoma Drainage Devices market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Glaucoma drainage implants are small prosthetic devices that are placed to help lower the intraocular pressure and prevent further optic nerve damage. Glaucoma drainage implant surgery is an alternative to Glaucoma Filtration Surgery (Trabeculectomy). In some patients, particularly those with certain types of glaucoma such as aphakic glaucoma, neovascular glaucoma, and uveitic glaucoma, trabeculectomies are known to be less successful at reducing intraocular pressure due to an aggressive healing response. Also, in patients who have had other eye surgeries, a glaucoma drainage device often works better than a trabeculectomy procedure to control the intraocular pressure.One type of incisional glaucoma surgery uses a tube shunt, which is a flexible glaucoma drainage device that is implanted in the eye to divert aqueous humor (the fluid inside the eye) from the inside of the eye to an external reservoir. Aqueous shunts are artificial filtering devices which lower the intraocular pressure (IOP) by draining aqueous humor to the external subconjunctival space. Aqueous shunts are increasingly utilized in the management of refractory glaucoma.
Minimally Invasive Glaucoma Surgery or ‘MIGS’ is a term applied, more or less appropriately, to the widening range of implants, devices and techniques that seek to lower intraocular pressure with less surgical risk than the more established procedures (of trabeculectomy, non-penetrating procedures (deep sclerectomy, canaloplasty, viscocanulostomy etc.) and tube drainage devices.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Glaucoma Drainage Devices Industry. Request a Free Sample PDF!
Hospital, an institution that is built, staffed, and equipped for the diagnosis of disease; for the treatment, both medical and surgical, of the sick and the injured; and for their housing during this process. The modern hospital also often serves as a centre for investigation and for teaching. To better serve the wide-ranging needs of the community, the modern hospital has often developed outpatient facilities, as well as emergency, psychiatric, and rehabilitation services.
Clinic, an organized medical service offering diagnostic, therapeutic, or preventive outpatient services. Being an outpatient means that you can go home after you receive care. Clinics can be privately operated or publicly managed and funded. They typically cover the primary care needs of populations in local communities, in contrast to larger hospitals which offer more specialized treatments and admit inpatients for overnight stays. While many clinics offer more general healthcare services, some clinics are more specialized. These types of clinics may be focused on areas like mental health, sexual health, or addiction services.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | Implants & Shunts, MIGS |
Application | Hospitals, Physicians (Clinics) |
List of Competitors | Alcon, Henan Universe IOL Researching, Glaukos Corporation, Allergan Plc |
This chapter will help you gain GLOBAL Market Analysis of Glaucoma Drainage Devices. Further deep in this chapter, you will be able to review Global Glaucoma Drainage Devices Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Glaucoma Drainage Devices. Further deep in this chapter, you will be able to review North America Glaucoma Drainage Devices Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Glaucoma Drainage Devices. Further deep in this chapter, you will be able to review Europe Glaucoma Drainage Devices Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Glaucoma Drainage Devices. Further deep in this chapter, you will be able to review Asia Pacific Glaucoma Drainage Devices Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Glaucoma Drainage Devices. Further deep in this chapter, you will be able to review South America Glaucoma Drainage Devices Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Glaucoma Drainage Devices. Further deep in this chapter, you will be able to review Middle East Glaucoma Drainage Devices Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Glaucoma Drainage Devices. Further deep in this chapter, you will be able to review Middle East Glaucoma Drainage Devices Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Glaucoma Drainage Devices. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Glaucoma Drainage Devices market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 13 Research Methodology and Sources
Why Implants & Shunts have a significant impact on Glaucoma Drainage Devices market? |
What are the key factors affecting the Implants & Shunts and MIGS of Glaucoma Drainage Devices Market? |
What is the CAGR/Growth Rate of Hospitals during the forecast period? |
By type, which segment accounted for largest share of the global Glaucoma Drainage Devices Market? |
Which region is expected to dominate the global Glaucoma Drainage Devices Market within the forecast period? |